U.S. Physical Therapy Inc. (NYSE:USPH) CEO Christopher J. Reading sold 8,000 shares of the company’s stock in a transaction dated Monday, September 19th. The stock was sold at an average price of $64.01, for a total transaction of $512,080.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

U.S. Physical Therapy Inc. (NYSE:USPH) opened at 63.00 on Thursday. The company’s 50 day moving average is $62.44 and its 200 day moving average is $56.92. U.S. Physical Therapy Inc. has a 52 week low of $42.59 and a 52 week high of $64.89. The stock has a market cap of $788.76 million, a P/E ratio of 32.47 and a beta of 0.76.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Thursday, August 4th. The company reported $0.57 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.55 by $0.02. The firm had revenue of $90.40 million for the quarter, compared to the consensus estimate of $90.01 million. U.S. Physical Therapy had a net margin of 6.95% and a return on equity of 12.06%. U.S. Physical Therapy’s quarterly revenue was up 8.5% compared to the same quarter last year. During the same period last year, the firm posted $0.51 EPS. Equities analysts predict that U.S. Physical Therapy Inc. will post $1.99 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 2nd. Investors of record on Friday, August 19th were given a $0.17 dividend. The ex-dividend date was Wednesday, August 17th. This represents a $0.68 annualized dividend and a yield of 1.08%. U.S. Physical Therapy’s dividend payout ratio is presently 34.87%.

Several research firms have recently commented on USPH. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $68.00 price target on the stock in a research report on Tuesday, August 9th. Jefferies Group set a $65.00 price target on shares of U.S. Physical Therapy and gave the company a “hold” rating in a research report on Friday, August 5th. Finally, Barrington Research lowered shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research report on Friday, August 5th.

A number of hedge funds have recently modified their holdings of the stock. Bank of Montreal Can purchased a new stake in shares of U.S. Physical Therapy during the second quarter valued at $14,047,000. Neuberger Berman Group LLC increased its stake in shares of U.S. Physical Therapy by 24.6% in the second quarter. Neuberger Berman Group LLC now owns 947,897 shares of the company’s stock valued at $57,073,000 after buying an additional 187,395 shares in the last quarter. Emerald Acquisition Ltd. purchased a new stake in shares of U.S. Physical Therapy during the second quarter valued at $8,522,000. Aberdeen Asset Management PLC UK increased its stake in shares of U.S. Physical Therapy by 65.3% in the second quarter. Aberdeen Asset Management PLC UK now owns 321,707 shares of the company’s stock valued at $19,370,000 after buying an additional 127,094 shares in the last quarter. Finally, Schroder Investment Management Group purchased a new stake in shares of U.S. Physical Therapy during the second quarter valued at $6,219,000. Hedge funds and other institutional investors own 98.33% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.